GlassScriptPhysician profile
Tomika M Williams
NPI 1518938323
$1,153.44
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $613 · 2022: $540.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $213.61 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $125.84 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $122.24 | 2021 | |
| Merck Sharp & Dohme LLC | $88.74 | 2021 | |
| Lilly USA, LLC | $71.74 | 2021-2022 | |
| Smith+Nephew, INC. | $70.05 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $64.33 | 2021 | |
| Amarin Pharma, INC. | $63.43 | 2021 | |
| Eisai INC. | $62.36 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $50.00 | 2022 | |
| Ironwood Pharmaceuticals, INC | $32.43 | 2021 | |
| Xeris Pharmaceuticals, INC. | $29.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $27.18 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.40 | 2022 | |
| Alkermes, INC. | $19.90 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.81 | 2021 | |
| Esperion Therapeutics, INC. | $15.71 | 2021 | |
| Amgen INC. | $14.70 | 2022 | |
| Astellas Pharma US INC | $13.91 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomika Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.